Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500μg vs Fluticasone Propionate 500μg in Patients with Corticosteroid-Dependent Asthma V: Results

被引：0
|
作者：
Willem R. Pieters
Bo Lundbäck
Seema Sondhi
Martin J. Price
Robert M.A. Thwaites
机构：
[1] Elkerliek Ziekenhuis,Respiratory Unit
[2] National Institute for Working Life,Global Health Outcomes
[3] Glaxo Wellcome,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Asthma; Adis International Limited; Fluticasone Propionate; Salmeterol; Formoterol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Methods: An economic analysis was performed to compare the cost effectiveness of a new formulation combining salmeterol 50μg and fluticasone propionate 500μg in a multidose dry powder (Diskus™) inhaler (n = 167) with that of fluticasone propionate (FP) 500μg (n = 165) also delivered via the Diskus™ in patients with corticosteroid-dependent asthma. Clinical data were obtained from a recent European multicentre trial; the economic analysis adopted a Swedish healthcare perspective.
引用
收藏
页码：29 / 34
页数：5
相关论文
共 49 条
  • [1] Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/250μg vs Fluticasone Propionate 250μg in Adults and Adolescents with Asthma IV: Results
    Mona Palmqvist
    Martin J. Price
    Seema Sondhi
    PharmacoEconomics, 1999, 16 : 23 - 28
  • [2] Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100μg vs Fluticasone Propionate 100μg in Adults and Adolescents with Asthma III: Results
    Gunnar Johansson
    Martin J. Price
    Seema Sondhi
    PharmacoEconomics, 1999, 16 : 15 - 21
  • [3] Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma II:: Study methodologies
    Pieters, WR
    Lundbäck, B
    Johansson, G
    Palmqvist, M
    Price, MJ
    Sondhi, S
    Thwaites, RMA
    Yan, SK
    PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 9 - 14
  • [4] Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview
    Bo Lundbäck
    Willem R. Pieters
    Gunnar Johansson
    Mona Palmqvist
    Martin J. Price
    Seema Sondhi
    Robert M.A. Thwaites
    PharmacoEconomics, 1999, 16 : 1 - 8
  • [5] Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies
    Willem R. Pieters
    Bo Lundbäck
    Gunnar Johansson
    Mona Palmqvist
    Martin J. Price
    Seema Sondhi
    Robert M.A. Thwaites
    Songkai Yan
    PharmacoEconomics, 1999, 16 : 9 - 14
  • [6] Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma
    Bergmann, KC
    Lindemann, L
    Braun, R
    Steinkamp, G
    SWISS MEDICAL WEEKLY, 2004, 134 (3-4) : 50 - 58
  • [7] Cost-effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
    Tohda, Yuji
    Nishima, Sankei
    Arakawa, Ichiro
    Shiragami, Makoto
    Miyamoto, Terumasa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (04): : 593 - 603
  • [8] COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada
    Ismaila, Afisi S.
    Risebrough, Nancy
    Li, Chunmei
    Corriveau, Diane
    Hawkins, Neil
    FitzGerald, J. Mark
    Su, Zhen
    RESPIRATORY MEDICINE, 2014, 108 (09) : 1292 - 1302
  • [9] Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma
    Richard D. O’Connor
    Harold Nelson
    Rohit Borker
    Amanda Emmett
    Priti Jhingran
    Kathleen Rickard
    Paul Dorinsky
    PharmacoEconomics, 2004, 22 : 815 - 825
  • [10] Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
    Ferguson, Gary T.
    Anzueto, Antonio
    Fei, Richard
    Emmett, Amanda
    Knobil, Katharine
    Kalberg, Christopher
    RESPIRATORY MEDICINE, 2008, 102 (08) : 1099 - 1108
12345